Steven A. Rosenberg

Researcher Next ID · RN-001145

Researcher · Immunology and Microbiology

Bethesda, United States

Not currently recruitingFunding unknown

Research interests

Immunology and Microbiology

Medicine

Biochemistry, Genetics and Molecular Biology

Immunotherapy and Immune Responses

CAR-T cell therapy research

Cancer Immunotherapy and Biomarkers

Immune Cell Function and Interaction

Virus-based gene therapy research

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)61403-3
Cancer immunotherapy: moving beyond current vaccines
Nature Medicine · 2004 · https://doi.org/10.1038/nm1100
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa021491
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Science · 2002 · https://doi.org/10.1126/science.1076514
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
New England Journal of Medicine · 1987 · https://doi.org/10.1056/nejm198704093161501

No projects listed.